Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells
- PMID: 21881969
- PMCID: PMC5771409
- DOI: 10.1007/s00198-011-1728-5
Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells
Abstract
We profiled the global gene expression of a bone marrow-derived mesenchymal pluripotent cell line in response to Runx2 expression. Besides osteoblast differentiation, Runx2 promoted the osteoclastogenesis of co-cultured splenocytes. This was attributable to the upregulation of many novel osteoclastogenic genes and the downregulation of anti-osteoclastogenic genes.
Introduction: In addition to being a master regulator for osteoblast differentiation, Runx2 controls osteoblast-driven osteoclastogenesis. Previous studies profiling gene expression during osteoblast differentiation had limited focus on Runx2 or paid little attention to its role in mediating osteoblast-driven osteoclastogenesis.
Methods: ST2/Rx2(dox), a bone marrow-derived mesenchymal pluripotent cell line that expresses Runx2 in response to Doxycycline (Dox), was used to profile Runx2-induced gene expression changes. Runx2-induced osteoblast differentiation was assessed based on alkaline phosphatase staining and expression of classical marker genes. Osteoclastogenic potential was evaluated by TRAP staining of osteoclasts that differentiated from primary murine splenocytes co-cultured with the ST2/Rx2(dox) cells. The BeadChip™ platform (Illumina) was used to interrogate genome-wide expression changes in ST2/Rx2(dox) cultures after treatment with Dox or vehicle for 24 or 48 h. Expression of selected genes was also measured by RT-qPCR.
Results: Dox-mediated Runx2 induction in ST2 cells stimulated their own differentiation along the osteoblast lineage and the differentiation of co-cultured splenocytes into osteoclasts. The latter was attributable to the stimulation of osteoclastogenic genes such as Sema7a, Ltc4s, Efnb1, Apcdd1, and Tnc as well as the inhibition of anti-osteoclastogenic genes such as Tnfrsf11b (OPG), Sema3a, Slco2b1, Ogn, Clec2d (Ocil), Il1rn, and Rspo2.
Conclusion: Direct control of osteoblast differentiation and concomitant indirect control of osteoclast differentiation, both through the activity of Runx2 in pre-osteoblasts, constitute a novel mechanism of coordination with a potential crucial role in coupling bone formation and resorption.
Conflict of interest statement
Figures





Similar articles
-
Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.Bone. 2015 Jun;75:96-104. doi: 10.1016/j.bone.2015.02.007. Epub 2015 Feb 17. Bone. 2015. PMID: 25701138 Free PMC article.
-
Glucocorticoids Hijack Runx2 to Stimulate Wif1 for Suppression of Osteoblast Growth and Differentiation.J Cell Physiol. 2017 Jan;232(1):145-53. doi: 10.1002/jcp.25399. Epub 2016 Apr 26. J Cell Physiol. 2017. PMID: 27061521 Free PMC article.
-
Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells.J Cell Biochem. 2014 Jan;115(1):27-33. doi: 10.1002/jcb.24646. J Cell Biochem. 2014. PMID: 23943595 Free PMC article.
-
Regulation of bone development and extracellular matrix protein genes by RUNX2.Cell Tissue Res. 2010 Jan;339(1):189-95. doi: 10.1007/s00441-009-0832-8. Epub 2009 Aug 1. Cell Tissue Res. 2010. PMID: 19649655 Review.
-
Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2.Int J Mol Sci. 2019 Apr 4;20(7):1694. doi: 10.3390/ijms20071694. Int J Mol Sci. 2019. PMID: 30987410 Free PMC article. Review.
Cited by
-
Heparin-binding EGF-like growth factor and miR-1192 exert opposite effect on Runx2-induced osteogenic differentiation.Cell Death Dis. 2013 Oct 17;4(10):e868. doi: 10.1038/cddis.2013.363. Cell Death Dis. 2013. PMID: 24136232 Free PMC article.
-
Estrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanisms.J Cell Physiol. 2017 Dec;232(12):3798-3807. doi: 10.1002/jcp.25862. Epub 2017 May 11. J Cell Physiol. 2017. PMID: 28213978 Free PMC article.
-
Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.Bone. 2015 Jun;75:96-104. doi: 10.1016/j.bone.2015.02.007. Epub 2015 Feb 17. Bone. 2015. PMID: 25701138 Free PMC article.
-
Extracellular Vesicles in Bone Homeostasis: Emerging Mediators of Osteoimmune Interactions and Promising Therapeutic Targets.Int J Biol Sci. 2022 Jun 21;18(10):4088-4100. doi: 10.7150/ijbs.69816. eCollection 2022. Int J Biol Sci. 2022. PMID: 35844790 Free PMC article. Review.
-
Human ectodermal organoids reveal the cellular origin of DiGeorge Syndrome.bioRxiv [Preprint]. 2025 Aug 8:2025.08.08.669417. doi: 10.1101/2025.08.08.669417. bioRxiv. 2025. PMID: 40855884 Free PMC article. Preprint.
References
-
- Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755–764. - PubMed
-
- Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997;89:765–771. - PubMed
-
- Zhang YW, Yasui N, Kakazu N, Abe T, Takada K, Imai S, Sato M, Nomura S, Ochi T, Okuzumi S, Nogami H, Nagai T, Ohashi H, Ito Y. PEBP2alphaA/CBFA1 mutations in Japanese cleidocranial dysplasia patients. Gene. 2000;244:21–28. - PubMed
-
- Vaughan T, Pasco JA, Kotowicz MA, Nicholson GC, Morrison NA. Alleles of RUNX2/CBFA1 gene are associated with differences in bone mineral density and risk of fracture. J Bone Miner Res. 2002;17:1527–1534. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous